TP53 and small cell lung carcinoma: Canonical driver mutations commonly seen in high-grade neuroendocrine carcinomas of the lung, such as TP53 and RB1, are rare (<5%) in LNETs, supporting the hypothesis that these tumors do not represent precursor lesions of typical SCLC but rather follow distinct tumorigenic trajectories [26].